PierianDx aims to improve diagnosis for chronic disease, including cancer


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
PierianDx aims to democratise clinical next-generation sequencing. By making precision medicine more accessible they want to improve the overall healthcare output.

In 2003, Washington University made the first-ever breakthrough of mapping the first human genome. Years later in 2011, the University was able to successfully create Clinical Genomics Workspace (CGW), a kind of software specifically made for clinical genomics. It streamlines and provides accurate analysis and conclusions of medical programs. 

Soon Washington University made a technology transfer to Rakesh Nagarajan’s budding venture PierianDx in 2014. PierianDx’s first solution was in collaboration with the University’s Department of Pathology & Immunology and Genetics. The University was the first one to acknowledge and validate next-generation clinical sequencing. 

PierianDx aims to democratise clinical next-generation sequencing. They work towards improving diagnosis for chronic disease, including cancer, and creating targeted treatments for the patients. By making precision medicine more accessible they want to improve the overall healthcare output. 

The startup received instant success. By 2015, they had received 14.2 million in its Series A round. Some of its investors are Health Catalyst Capital, Inova Health Systems, RTI International and ARUP Laboratories. In 2016, they opened their office in Pune to advance and develop their software. Within four years of their establishment, they had gained 40+ customers. In 2019, they partnered with the industry leader Illumina. 

ATW Partners and SJF Ventures raised an additional $27 million in 2019. Their post-money valuation was in the range of $100-500 million in the same year. By the end of 2019, PierianDx had expanded into Asia Pacific, Europe and the Middle East. They now collaborate with 100 plus clinical institutions.

Will the company achieve their dream of democratising next-generation sequencing a reality for every Indian? The company currently faces the challenge of making genomic testing with reduced cost and with a better turnaround time. This is slowing down the pace of adoption in India’s healthcare sector. Affordability is the biggest hurdle any health-tech company faces when it comes to popularizing it to the masses.

Tags : #PierianDx #RakeshNagarajan #next-generationsequencing #WashingtonUniversity #Illumina #cancerdiagnosis #personalisedtreatment #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026